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Abstract
The sialidase activity of neuraminidase-1 (Neu-1) is responsible for ERK 1/2 pathway activation following binding of elastin
peptide on the elastin receptor complex. In this work, we demonstrate that the receptor and lipid rafts colocalize at the
plasma membrane. We also show that the disruption of these microdomains as well as their depletion in glycolipids blocks
the receptor signaling. Following elastin peptide treatment, the cellular GM3 level decreases while lactosylceramide (LacCer)
content increases consistently with a GM3/LacCer conversion. The use of lactose or Neu-1 siRNA blocks this process
suggesting that the elastin receptor complex is responsible for this lipid conversion. Flow cytometry analysis confirms this
elastin peptide-driven LacCer generation. Further, the use of a monoclonal anti-GM3 blocking antibody shows that GM3 is
required for signaling. In conclusion, our data strongly suggest that Neu-1-dependent GM3/LacCer conversion is the key
event leading to signaling by the elastin receptor complex. As a consequence, we propose that LacCer is an early messenger
for this receptor.
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Introduction
Elastin is the extracellular matrix protein responsible for the
elasticity of tissues where resilience is required such as skin, large
arteries or lung [1]. This protein can be degraded in elastin
peptides. Unlike elastin, some of these fragments (i.e. those
presenting the GXXPG pattern) exhibit a strong biological activity
[2]. These elastin peptides, or elastokines, are produced during
various physiological processes following the action of elastases.
Elastin peptides regulate several biological functions such as
chemotaxis [3,4], proliferation [5], proteases synthesis [6,7] in
normal and tumor cells suggesting that they are involved in tumor
progression [2] and vascular pathologies [8].
The biological activity of elastin peptides is regulated by their
binding to the elastin receptor complex. In human, this complex
comprises three sub-units: a peripheral protein of 67 kDa called
elastin binding protein (EBP, accession number P16279) and two
membrane-associated proteins, protective protein/cathepsin A
(PPCA, accession number P10619) and neuraminidase-1 (Neu-1,
accession number Q99519) of 55 kDa and 61 kDa respectively
[9]. EBP is an enzymatically spliced variant of the lysosomal b-
galactosidase (b-Gal, EC 3.2.1.23). Elastokines binding on EBP
triggers the elastin receptor complex association and induces signal
transduction whereas occupancy of EBP galactolectin site by
galactosides causes elastin peptides release, dissociation of the
complex and signal loss [2].
We have recently shown that elastin peptides binding to EBP
leads to Neu-1 activation and that the induction of this sialidase
activity is required for signal propagation and further induction of
the extracellular signal-regulated kinase 1/2 (ERK 1/2) pathway
[9,10]. However, it has to be emphasized here that the substrates
desialylated by Neu-1 remain unknown.
Neu-1 is present at the plasma membrane but it is also located in
lysosomes where it is associated to b-Gal and PPCA. In the
lysosome, PPCA protects b-Gal and Neu-1 from intralysosomal
digestion independently of its serine-protease activity [11]. Neu-1 is
a member of the sialidase family and catalyzes the removal of sialic
acids from the sugar chains of glycoproteins and glycolipids [12,13].
Seyrantepe and co-workers [13] have shown that the glycosphin-
golipid N-acetylneuraminic-a (2-3)-galactosyl-b (1-4)-glucosyl-b
(1-1’)-ceramide acid, or GM3 ganglioside, is a substrate of Neu-1.
Gangliosides are sialic acid-containing glycosphingolipids found
in the outer leaflet of the plasma membrane of vertebrate cells
[14]. Gangliosides are amphiphilic molecules consisting of an
oligosaccharidic chain of variable length and complexity bound to
a ceramide anchor. These molecules belong to the glycosphingo-
lipid family and are characterized by the presence of one or more
sialic acid residues [15]. Gangliosides are involved in cellular
interactions and in signal transduction [16]. Lactosylceramide
(LacCer), GM3 ganglioside precursor, is involved in fibroblast
proliferation [17], ERK 1/2 activation in smooth muscles cells
[18] and angiogenesis [19].
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mains enriched in cholesterol, glycosphingolipids and transmem-
brane proteins [20]. Within rafts, glycosphingolipids are specifi-
cally enriched at the exoplasmic leaflet while glycerolipids reside in
the cytoplasmic leaflet and cholesterol in the inner spaces [21].
Rafts are important signaling platforms and numerous signal
transduction schemes have been linked to their presence [20,22].
In this study, we show that, following elastin peptides binding on
EBP, the Neu-1 sub-unit of the elastin receptor complex converts
the GM3 ganglioside to LacCer and that this conversion leads to
intracellular signaling. As a consequence, we propose that the
Neu-1-driven GM3/LacCer conversion occurring in rafts after
treatment with elastin peptides is the key element of elastin
signaling in cells.
Methods
Ethics statement
Human skin fibroblasts were established from explants of
human adult skin biopsies obtained from informed healthy
volunteers (aged 21–49 years) who have given their written
consent. The experiments were conducted according with the
recommendations of "Le Centre National de la Recherche
Scientifique" (CNRS, France) which has specifically approved this
study.
Reagents
Elastin peptides were prepared as described previously [7].
Briefly, insoluble elastin was prepared from bovine ligamentum
nuchae by hot alkali treatment. Its purity was assessed by comparing
its amino acid composition to that predicted from the elastin gene
product. Soluble elastin peptides were further obtained from
insoluble elastin by organo-alkaline hydrolysis. This was achieved
using 1 M KOH in 80% aqueous ethanol [23]. The obtained
mixture of elastin peptides is termed k-elastin (kE) and exhibits the
same biological properties as physiological elastin hydrolysates
obtained using elastase [7]. Dulbecco’s Modified Eagle’s Medium
(DMEM) was purchased from Invitrogen (Cergy Pontoise,
France). Fetal calf serum (FCS) was obtained from Pan Biotech
GmbH distributed by Dutscher (Brumath, France). Methyl-b-
cyclodextrin (MCD), protease inhibitor cocktail, MTT and lactose
were purchased from Sigma-Aldrich (Saint Quentin Fallavier,
France). [1-
3H] sphingosine, glycosphingolipid biosynthesis pre-
cursor, was obtained from Perkin Elmer (Courtaboeuf, France).
HPTLC sheets were purchased from Merck Biosciences distrib-
uted by VWR (Strasbourg, France). BCAssay Protein Quantita-
tion Kit was purchased from Interchim (Montluc ¸on, France). D-
threo-1-phenyl-2-decanoylamino-3-morpholino-4 propanol (D-
PDMP) was obtained from Matreya, Biovalley (Marne la Valle ´e,
France). AlexaFluor 488-cholera toxin B sub-unit and streptavidin-
AlexaFluor 568 were purchased from Molecular Probes (distrib-
uted by Invitrogen).
Antibodies
The rabbit polyclonal anti-EBP antibody was raised against the
EBP specific segment coupled to a GST carrier. IgG were purified
and those raised against GST were removed by GST-sepharose
affinity. Monoclonal anti-b-actin, anti-mouse and mouse anti-IgG
horseradish peroxydase-coupled antibodies were purchased from
Sigma-Aldrich. Monoclonal anti-GM3 antibody (ref M2590) was
obtained from Cosmo Bio (Tokyo, Japan). Anti-cholera toxin B
sub-unit antibody was purchased from Molecular Probes.
Polyclonal anti-phospho-ERK1/2 (T202/Y204), anti-ERK 1/2
and horseradish peroxidase-coupled anti-rabbit antibodies were
obtained from Cell Signaling Technology Inc. (Beverly, MA,
distributed by Ozyme, Saint Quentin en Yvelines, France). Biotin-
anti-IgG rabbit antibody was purchased from Jackson ImmunoR-
esearch distributed by Interchim. FITC-anti-IgM control antibody
was purchased from Miltenyi Biotec (Paris, France). FITC-anti-
CD17 antibody (anti-lactosylceramide) was obtained from Ancell
distributed by Covalab (Villeurbanne, France). Polyclonal anti-
Neu-1 antibody was purchased from Santa Cruz Biotechnology
(distributed by Tebu, Le Perray en Yvelines, France). Monoclonal
blocking antibodies directed against avb3 and galectin-3 (Gal3)
were purchased from Millipore (Molsheim, France).
Fibroblast culture and treatments
Human skin fibroblasts were established from explants of
human adult skin biopsies obtained from informed healthy
volunteers (aged 21–49 years) as previously described using cell
culture medium selection [24]. Cells were grown as monolayer
cultures in DMEM containing 1 g/l of glucose, glutamax I and
pyruvate, supplemented with 10% FCS and in the presence of
5% CO2. Cells at sub-cultures 4 to 8 were used. For experiments,
fibroblasts were grown to sub-confluence in medium containing
10% FCS. Before stimulation, cells were incubated for 18 h in
DMEM supplemented with 0.5% FCS, washed twice with PBS
and incubated in serum-free DMEM with or without kE and the
different inhibitors, antagonists and blocking antibodies for the
indicated times. Cell survival following D-PDMP treatment was
evaluated using MTT assay following manufacturer’s instruction.
The different modulators were present in the cell culture media
during the stimulation. Cell stimulation was stopped by adding
ice-cold phosphate buffered saline (PBS) containing 50 mM
Na3VO4.
Immunocytochemistry
Cells cultured on 24-well plates containing cover glasses were
washed with PBS (pH 7.4) and fixed 5 min at room temperature
with 4% formaldehyde (w/v) in PBS. After PBS washings, the cell
layer was saturated with 10% normal goat serum (NGS) in PBS
during 30 min at room temperature. The anti-EBP antibody (1/
10 dilution) was incubated for 1 h. A Biotin-anti-IgG rabbit
antibody (1/50 dilution) in 3% NGS was incubated at room
temperature during 30 min. Cells were incubated for 30 min with
streptavidin-AlexaFluor 568. Cover glasses were incubated with
AlexaFluor 488- cholera toxin B sub-unit diluted to 1/1000 in
DMEM for 10 min at 4uC in darkness. Cells were washed and an
anti-cholera toxin B sub-unit antibody (1/200) was added during
15 min at 4uC. Cells were observed with a Bio-Rad 1024 S
confocal microscope (Bio-Rad, Marne-la-Valle ´e, France).
Lipid analysis
Fibroblasts were incubated in the presence of 0.4 mCi [1-
3H]
sphingosine. After 2 h of incubation (pulse), the medium was
removed. Cells were washed with PBS and incubated for 48 h
(chase) with DMEM devoid of radioactive precursors in the
presence of 10% FCS [25]. At the end of the chase, the medium
was carefully collected and cells were harvested by scrapping with
a rubber policeman. Cell suspensions were mixed with a
chloroform/methanol (2:1, v/v) mixture and centrifuged (5000 g,
10 min, 4uC). Lipids were analyzed by HPTLC using a
chloroform/methanol/0.2% aqueous CaCl2 (60:40:9, v/v/v)
mixture to separate aqueous phase and a chloroform/methanol/
water (55:20:3, v/v/v) mixture, to isolate organic phase lipids.
After 90 min, HPTLC sheets were revealed with iodine, covered
by a KODAK MS film and stored at -80uC in a cassette.
Elastin Receptor Signaling
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After stimulation, fibroblasts were washed with ice-cold PBS
containing 50 mMN a 3VO4 and harvested using PBS EDTA
10 mM at 4uC. Cells were centrifuged (400 g, 10 min, 4uC),
washed with PBS, then incubated with FITC-anti-CD 17 antibody
(anti-lactosylceramide) or FITC-anti-IgM control (1/25 dilution)
for 20 min at room temperature in darkness. Cells were then
washed, centrifuged and fixed with 500 ml of 1% formaldehyde
before being analyzed with a FACS Calibur cytometer (Becton
Dickinson, Le Pont de Claix, France).
Western-blotting
Fibroblasts (10
6) were washed twice in ice-cold PBS containing
50 mMN a 3VO4, scrapped and sonicated in lysis buffer (PBS,
pH 7.4, 0.5% Triton X-100, 80 mM glycerophosphate, 50 mM
EGTA, 15 mM MgCl2, 1 mM Na3VO4, and protease inhibitor
cocktail). Insoluble material was removed by centrifugation
(20000 g, 20 min, 4uC). Protein concentrations were determined
by BCAssay Protein Quantitation Kit. Equal amounts of proteins
were heated for 5 min at 100uC in Laemmli sample buffer,
resolved by SDS-PAGE under reducing conditions and transferred
to nitrocellulose membranes. The membranes were placed in
blocking buffer (5% (w/v) nonfat dry milk in Tris-buffered saline/
Tween 20 (50 mM Tris, pH 7.5, 150 mM NaCl, and 0.1% (v/v)
Tween 20)) for 1 h at room temperature and incubated overnight
at 4uC with anti-phospho-ERK1/2 (T202/Y204), anti-ERK 1/2
(1/1000), anti-Neu-1 (1/200) or anti-b-actin (1/4000) antibodies.
After five washings with Tris-buffered saline/Tween 20, mem-
branes were incubated for 1 h at room temperature in the
presence of horseradish peroxidase-coupled anti-rabbit antibodies
or horseradish peroxidase-coupled anti-mouse antibodies (1/4000
and 1/10000 in blocking buffer, respectively). Immuno-complexes
were detected by chemiluminescence. In order to evaluate ERK
1/2 phosphorylation, observed bands were analyzed using the
densitometric PhosphorAnalyst software (Bio-Rad).
Neu-1 siRNA gene silencing
Fibroblasts were grown on 6-well plates to 70% confluency in
DMEM containing 1 g/l of glucose, glutamax I and pyruvate,
supplemented with 10% FCS and in the presence of 5% CO2. For
siRNA transfection, we used the predesigned silencer Neu-1
siRNA from Ambion (59-GGCGAGGAAAAUGUCCUCATT-39
(forward), 59-UGAGGACAUUUUCCUCGCCTC-39 (reverse);
ID: 8481, distributed by Applied Biosystems, Courtaboeuf,
France) as they are very efficient Neu-1 siRNA [9]. The negative
control siRNA (SNC siRNA) was also purchased from Ambion
(cat. nuAM4611). Cells were trypsinized, centrifuged (400 g,
10 min, 20uC), then 400 000 cells were nucleofected. After
nucleofection (Nucleofector, Amaxa Biosystems, Germany) with
Neu-1 or SNC siRNA (100 pmol), fibroblasts were cultured on 6-
well plates for 48 h and cell extracts were analyzed by Western-
blotting as described above.
Statistical analysis
All experiments were performed three times in triplicate.
Results are expressed as mean +/2 S.E.M. Comparison between
groups were made using Student’s t test. The results were
considered significantly different at p,0.05.
Results
EBP and lipid rafts colocalize at the plasma membrane
Among glycosphingolipids which are concentrated in lipid rafts,
the GM3 ganglioside has been described as a substrate of Neu-1
[13,15,20]. As a consequence, we first checked the relative
localization of EBP and of these microdomains. This was achieved
by a double immunocytochemical staining followed by fluores-
cence microscopy imaging (Fig. 1). We observed a homogeneous
distribution of EBP and lipid rafts on the plasma membrane of
human dermal fibroblasts and the merge of the obtained images
indicated that these entities colocalized.
Lipid rafts integrity is required for elastin peptide-
induced signal transduction
Lipid rafts are plasma membrane microdomains specialized in
signaling. They are enriched in cholesterol and this lipid is
necessary for their function. MCD is a derivative of a glucose
cyclic oligomer with a lipophilic property. It has the ability to
extract cholesterol from membranes and is therefore commonly
used to study the role of rafts in biological processes [20].
Consequently, cholesterol depletion using MCD selectively occurs
in rafts and pathways inhibited by such a treatment are defined as
raft-dependent [26]. In fibroblasts, elastin peptides induce ERK
1/2 activation through the elastin receptor complex [9]. In order
to evaluate the role of these structures in elastin peptide-induced
signaling, we depleted the cholesterol from rafts using MCD and
tested afterwards the ability of elastin peptides to trigger ERK 1/2
activation (Fig. 2).
In the presence of elastin peptides, a 2.6 fold increase in ERK
1/2 activation was observed. This effect was totally lost when cells
had been formerly cholesterol-depleted by MCD. These results
strongly suggested that lipid rafts were important for signaling by
the elastin receptor complex.
Gangliosides are essential for elastin peptide-induced
signal transduction
Glycosphingolipids and especially gangliosides are major and
specific components of lipid rafts. They modulate several
aspects of signal transduction processes [15]. In order to
determine the role of these glycosphingolipids in elastin peptide-
induced signaling, we incubated cells with D-PDMP, an UDP-
glucose/galactose transferase in h i b i t o r[ 2 7 ] ,f o rs e v e r a ld a y ss o
as to totally deplete these lipids from cell membranes. The
analysis of fibroblasts gangliosides (Fig. 3A) evidenced large
GM3 and GD3 proportions as well as GM2 and GM1.D - P D M P
totally blocked gangliosides synthesis without inducing signifi-
cant cell death.
Fibroblasts lacking gangliosides totally failed to induce ERK 1/
2 activation after elastin peptides treatment (Fig. 3B and 3C). This
result suggests that the gangliosidic component of lipid rafts played
an essential role in elastin peptide-induced cell signaling.
GM3 is converted to LacCer following elastin peptides
treatment
GM3 ganglioside is a substrate of Neu-1 [13]. Its desialylation by
Neu-1 produces LacCer, a second messenger able to activate ERK
1/2 pathway [18]. In order to evaluate the influence of kE on
GM3 and LacCer levels, cellular gangliosides were labelled with
[1-
3H]-sphingosine and analyzed by HPTLC (Fig. 4A and 5A)
after cells were treated or not with elastin peptides. Our results
showed an inverse correlation between the GM3 and LacCer
levels. At 5 min stimulation, kE induced a 45% decrease of GM3
level and a 92% increase of LacCer level. This effect was amplified
at 30 min stimulation, showing a 68% decrease of GM3 level and
a 332% increase of LacCer level. These observations suggested
that GM3 was converted to LacCer after elastin peptides
treatment.
Elastin Receptor Signaling
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In order to determine the role of the elastin receptor complex in
this conversion, similar experiments were performed in the
presence of lactose, an EBP antagonist (Fig. 4B and 5B). We
noticed that the elastin peptide-induced GM3 decrease could not
be observed anymore in the presence of lactose. Moreover, the
formerly observed LacCer production increase was also blocked
when lactose was present in the medium.
As lactose inhibited elastin receptor complex-induced signaling,
these results strongly suggested that GM3/LacCer conversion
occurred when elastin peptides were bound on the EBP sub-unit of
the elastin receptor complex.
It has been demonstrated that elastin peptides promote Neu-1
activity which is responsible for signal transduction by the elastin
receptor complex [9]. In order to demonstrate Neu-1 involvement
in the observed GM3/LacCer conversion, sialidase silencing was
performed by nucleofection. When cells were transfected with
Neu-1 siRNA, Neu-1 expression was reduced by 73% in
fibroblasts (Fig. 6A and 6B). As shown by flow cytometry data
(Fig. 6C), a 5 min stimulation with kE induced LacCer production
in both control cells (+128%) and in SNC siRNA-transfected cells
(+112%). However, no fluorescence shift was observed for
stimulated Neu-1 siRNA-transfected cells demonstrating that
LacCer was not produced. These results supported our view that
LacCer was generated by Neu-1 following elastin peptides
treatment.
In order to show that the GM3 ganglioside could be the Neu-1
substrate giving rise to LacCer production, we used a monoclonal
anti-GM3 blocking antibody [28] and tested its effect on the ability
of cells to induce ERK 1/2 activation in the presence of elastin
peptides. As shown in Figure 7, the presence of the anti-GM3
antibody totally blocked elastin peptide-triggered ERK 1/2
activation suggesting that elastin receptor complex signaling was
possible only when GM3 was available. Finally, to exclude the
possible involvement of LacCer neosynthesis in the elastin peptide-
induced ERK1/2 activation, we used D-PDMP to block
lactosylceramide synthase activity as previously described [19].
Figure 1. EBP and lipid rafts are colocalized at the plasma membrane. EBP and lipid rafts localization were analyzed using confocal
microscopy as described in the Methods section. EBP appears as a red staining, lipid rafts as a green staining and the colocalization as a yellow
staining. The scale represents 10 mm.
doi:10.1371/journal.pone.0014010.g001
Figure 2. Lipid rafts integrity is required for elastin peptide-
induced signal transduction. A) Fibroblasts were incubated for
30 min with 10 mM MCD then treated with 50 mg kE/ml for 30 min.
Cellular extracts were analyzed by anti-phospho-ERK 1/2 (T202/Y204)
and anti-ERK 1/2 Western-blots. B) Densitometric analysis: ***, p,0.001.
doi:10.1371/journal.pone.0014010.g002
Elastin Receptor Signaling
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required for elastin peptide-induced signaling.
LacCer mimics elastin peptides effects
LacCer has been described as a second messenger able to
activate ERK 1/2 pathway in smooth muscle cells [18], fibroblasts
[17] and endothelial cells [19]. We thus decided to analyze the
potential early messenger role of LacCer in our system.
Cells were treated with different concentrations of exogenous
LacCer and its influence on ERK 1/2 activation was analyzed by
Western-blot (Fig. 8). The results indicated a dose-dependent ERK
1/2 activation with a maximal effect at 12.5 mM LacCer. Thus,
exogenous LacCer could reproduce the effects of elastin peptides
treatment.
In order to confirm that LacCer effect was due to cell
penetration, fibroblasts were incubated with BODIPY-labelled
LacCer (Fig. 9). Fluorescence microscopy observation revealed a
membrane staining and a cellular penetration of exogenous
LacCer. As a consequence, we concluded that LacCer generated
at the plasma membrane following GM3 conversion could explain
ERK 1/2 activation.
Figure 4. EBP is involved in the kE-induced GM3 levels
decrease. A) Fibroblasts were incubated for 2 h with [1-
3H]-
sphingosine, PBS washed, and radioactive staining of glycolipids was
performed for 48 h. Cells were then stimulated with or without 50 mg
kE/ml during 5 (dark grey) or 30 min (white). After extraction, lipids
were separated by HPTLC and the plates were put in the presence of a
radiographic film during one month at 280uC and revealed. GM3 was
identified comparing its migration rate to that of controls. Densito-
metric analysis: ***, p,0.001. B) The radioactive staining and the
stimulation have been performed as in A. Lactose (1 mM), an EBP
antagonist, was preincubated for 3 h before stimulation with kE (50 mg/
ml, 30 min). After extraction, lipids were separated by HPTLC and the
plates were put in presence of a radiographic film during one month at
280uC, and revealed. GM3 was identified by comparing its migration
rate to that of controls. Densitometric analysis: NS, not significant;
***, p,0.001.
doi:10.1371/journal.pone.0014010.g004
Figure 5. EBP is involved in the kE-induced LacCer production.
A) Radioactive staining and stimulation were performed as described in
Figure 5 caption. LacCer was identified by comparing its migration rate
to that of controls. Densitometric analysis: ***, p,0.001. B) Lactose
(1 mM) was preincubated for 3 h before stimulation with 50 mg kE/ml
for 30 min. After extraction, lipids were separed by HPTLC and the
plates were put in presence of a radiographic film during one month at
280uC, and then revealed. LacCer was identified comparing its
migration rate to that of controls. Densitometric analysis: ***, p,0.001.
doi:10.1371/journal.pone.0014010.g005
Figure 3. Gangliosides are essential for elastin peptide-induced signal transduction. A) Upper panel: Fibroblasts were incubated for 2 h
with [1-
3H]-sphingosine. The radioactive staining of glycolipids was realized for 48 h. Glycosphingolipids depletion was achieved by incubating cells
for 3 days with 20 mM D-PDMP. After extraction, lipids were resolved by HPTLC and the plates were put in presence of a radiographic film during one
month at 280uC, and then revealed. Lower panel: cell survival evaluated using MTT assay after D-PDMP incubation. B) Cells were incubated for 3 days
with 20 mM D-PDMP. Fibroblasts were then treated with 50 mg kE/ml for 30 min. Cellular extracts were analyzed by anti-phospho-ERK 1/2 (T202/Y204)
and ERK 1/2 Western-blots. The emergence of a third band in ERK1/2 Western-blots is due to an electrophoretic shift because of its phosphorylation.
C) Densitometric analysis: ***, p,0.001.
doi:10.1371/journal.pone.0014010.g003
Elastin Receptor Signaling
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The elastin receptor complex is found at the surface of
numerous cell types and its involvement in physiopathological
processes makes it a potential pharmacological target. The activity
of its Neu-1 sub-unit is responsible for its signaling transduction
capability but the substrates involved in this mechanism still
remain unknown.
Using immunocytochemical methods, we observed that lipid
rafts and EBP were colocalized in human dermal fibroblasts
(Fig. 1). This result suggested that these membrane microdomains
could be important to elastin receptor complex function.
We therefore used MCD to sequester cholesterol and deplete
lipid rafts in our cells. MCD treatment totally blocked kE-induced
ERK 1/2 activation (Fig. 2). This result demonstrated that intact
lipid rafts were required for proper elastin receptor signaling. Lipid
rafts are involved in numerous cellular processes and many studies
have shown their role in signal transduction [20]. Indeed, lipid
rafts are crucial to EGF receptor [29], insulin receptor [30], or
integrins [31] functioning. Our data suggest that the elastin
receptor complex is another lipid raft-dependent receptor.
Neu-1 activity is responsible for the elastin receptor complex
signaling [9] and gangliosides, glycosphingolipids signaling
regulators found in lipid rafts, are among its substrates [13]. In
order to address their importance in elastin receptor-mediated
signal transduction, we used D-PDMP to block their biosynthesis
in fibroblasts and checked the ability of these cells to respond to
elastin peptides stimuli. Consistent with the work of Makino and
co-workers [27], our results show that D-PDMP-treated cells are
devoid of gangliosides (Fig. 3A). Importantly, cell survival is not
affected. In the presence of elastin peptides, these cells failed to
activate the ERK 1/2 pathway (Fig. 3B and 3C). This point
suggested that the gangliosidic component of lipid rafts was crucial
for elastin receptor-induced signaling.
Glycosphingolipids and their metabolites are important in
various biological processes. Iwamoto and co-workers have
Figure 7. GM3 plays a substrate role for the elastin receptor
complex. A) Fibroblasts were incubated for 30 min with 10 mg/ml anti-
GM3 antibody then treated with 50 mg/ml kE for 30 min. Cell extracts
were analyzed by anti-phospho-ERK 1/2 (T202/Y204) and anti-ERK 1/2
Western-blots. The emergence of a third band in ERK1/2 western-blots
is due to an electrophoretic shift because of its phosphorylation. B)
Densitometric analysis: **, p,0.01.
doi:10.1371/journal.pone.0014010.g007
Figure 8. LacCer triggers ERK 1/2 activation. A) Fibroblasts were
incubated with different concentrations of LacCer for 30 min. Cell
extracts were analyzed by anti-phospho-ERK 1/2 (T202/Y204) Western-
blot. B) Densitometric analysis: **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0014010.g008
Figure 6. Neu-1 is involved in GM3/LacCer conversion. A) Cellular extracts from untransfected fibroblasts or cells transfected with SNC siRNA
or Neu-1 siRNA were analyzed by anti-Neu-1 Western-blot. B) Densitometric analysis: NS, not significant; ***, p,0.001. C) Untransfected fibroblasts
(control) and fibroblasts transfected with SNC siRNA or Neu-1 siRNA were stimulated with 50 mg/ml of kE. They were stained with or without an FITC-
anti-LacCer antibody (1/25 dilution) then analyzed by flow cytometry. The red line represents the control and the green one corresponds to the
stimulation with kE (50 mg/ml). D) Fibroblasts were pre-incubated with D-PDMP (20 mM) for 30 min prior to stimulation with kE (50 mg/ml, 30 min).
Cell extracts were analyzed by anti-phospho-ERK 1/2 (T202/Y204) and anti-ERK 1/2 Western-blots.
doi:10.1371/journal.pone.0014010.g006
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induced osteoclastogenesis [32]. The authors have shown that D-
PDMP strongly reduced the expression of RANK induced by
macrophage colony-stimulating factor. This effect was explained
by the inactivation of ERK 1/2. Our data are in agreement with
this signaling scheme.
Among gangliosides, we focused on GM3, a possible substrate of
Neu-1 [13] because its desialylation leads to LacCer production, a
second messenger regulating ERK 1/2 activation [18]. HPTLC
analysis of GM3 and LacCer indicated that kE induced a decrease
of GM3 level correlated to an increase of LacCer level. This effect
was maximum at 30 min (Fig. 4A and 5A), the time at which
maximum elastin peptide-induced ERK 1/2 activation is observed
[10]. This finding supported our hypothesis that kE treatment
leads to GM3/LacCer conversion eventually resulting in ERK 1/2
induction.
In order to determine if this conversion could involve the elastin
receptor complex, the previous experimentations were performed
in the presence of lactose, an EBP antagonist. The decrease of the
GM3 content and the increase of LacCer production occurring
after elastin peptides treatment were blocked in the presence of
lactose (Fig. 4B and 5B) suggesting that the EBP sub-unit of the
elastin receptor complex was involved in the GM3/LacCer
conversion mechanism. It has been suggested that Gal3, a
membrane receptor of galactolectin type, and avb3 integrin could
also bind elastin peptides [33]. Nevertheless, Gal3 and avb3
integrin involvement in this mechanism can be excluded because
our experiments with monoclonal anti-avb3 and anti-galectin-3
blocking antibodies demonstrated that these receptors were not
involved in kE-induced ERK1/2 activation (Table 1).
The elastin receptor complex involvement in LacCer produc-
tion following elastin peptides treatment was quantitated by flow
cytometry (Fig. 6C). We observed that fibroblasts in which the
Neu-1 sub-unit of the complex was silenced could no more initiate
LacCer production whereas fibroblasts transfected with a control
siRNA retained this possibility. These data strongly support our
view that the GM3/LacCer conversion occurring following elastin
peptides treatment relies on Neu-1 sialidase activity.
In order to confirm the substrate role of GM3 ganglioside, we
used a blocking monoclonal antibody directed against GM3 [28]
and observed that cells treated with this antibody could not
respond to the presence of elastin peptides in the medium (Fig. 7).
As a consequence, we concluded that GM3 is the substrate of
Neu-1.
We checked the messenger role of LacCer in elastin receptor
complex signaling by adding exogenous LacCer to fibroblasts in
culture. We showed that LacCer presence leads to an increase in
ERK 1/2 activation in a dose-dependent manner (Fig. 8) with a
maximal concentration at 12.5 mM. Our results are in agreement
with those of Chatterjee and co-workers [18] who observed that
10 mM LacCer induced ERK 1/2 activation in smooth muscle
cells. To verify that LacCer action was correlated to its penetration
into the plasma membrane, we used BODIPY-LacCer. [34]. Our
observations confirmed cell penetration of this lipid (Fig. 9),
explaining its bioactivity.
As a consequence, we propose that LacCer produced in the
plasma membrane by Neu-1-mediated GM3 conversion is an early
messenger of the elastin receptor complex. Further, we feel that
GM3/LacCer conversion could be a fundamental event of elastin
peptides biology as it could explain most aspects of their biological
activities. Indeed, a strong correlation exists between elastin
peptides biological effects and LacCer activities such as regulation
of cell proliferation [5,17], angiogenesis [19,35], activation of
ERK 1/2 [9,18]. Moreover, signaling by this glycosphingolipid
perfectly overlaps elastin peptide-derived signaling such as Ras
activation [36,37], cytosqueleton reorganization and Src activation
[35,37,38].
Importantly, our discovery that LacCer is an early messenger of
the elastin peptides receptor complex could have strong implica-
tions in ageing. Robert and co-workers [39] have underlined that a
large number of receptors functions are lost due to ageing. The
elastin receptor complex is one of them. With age, an uncoupling
of this receptor from its signaling pathways is observed although its
affinity for its cognate ligands remains unchanged in aged as
Figure 9. Exogenous LacCer penetrates into the plasma membrane. Fibroblasts were incubated with 12.5 mM BODIPY-LacCer
(lexcitation=505 nm; lemission=511 nm) for 30 min at 4uC followed by washings with defatted-BSA to remove any fluorescent lipid remaining at
the plasma membrane as described previously [38]. Cells were fixed then analyzed by fluorescence imaging. Hoechst 33342: nucleus staining by
Hoechst 33342 (lexcitation=340 nm; lemission=465 nm); BODIPY-LacCer: LacCer staining; Merge: superposition of nuclear and 12.5 mM BODIPY-
LacCer stainings. The scale represents 10 mm.
doi:10.1371/journal.pone.0014010.g009
Table 1. Influence of anti-avb3 and anti-galectin-3 blocking
antibodies on ERK1/2 activation.
ERK1/2 activity (%)
Control 100
kE 141,2661,93
kE + avb3 mAb 140,5862,31
kE + Gal3 mAb 140,2862,07
avb3 mAb 99,1661,02
Gal3 mAb 98,7261,39
Fibroblasts were pre-incubated with anti-avb3 or anti-galectin-3 blocking
antibodies (5 mg/ml) for 30 min before stimulation or not with kE (50 mg/ml;
30 min). ERK1/2 activity was assessed by Western-blots.
doi:10.1371/journal.pone.0014010.t001
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membrane lipid compositions, notably in rafts, could explain the
inability of aged cells to transduce signals originating from the
elastin receptor complex. Indeed, membrane gangliosides compo-
sition is largely age-dependent as old subjects possess less GM3
than young ones [40]. Consequently, stimulation of aged cells by
elastin peptides would lead to less LacCer production, thereby
explaining the apparent loss of function for their elastin receptor
complex.
In conclusion, our work shows that the elastin receptor complex
transduces its signals through an original mechanism involving
Neu-1-mediated GM3/LacCer conversion. Additionally, our
proposal could explain most elastin peptides biological effects
and their physiopathological consequences. These new data let us
foresee new approaches to block or strengthen elastin peptides
contribution in pathological or pharmacological situations.
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